TY - JOUR T1 - Co morbidity profile in patients with COPD: A prospective study from western part of India JF - European Respiratory Journal JO - Eur Respir J DO - 10.1183/13993003.congress-2015.PA1063 VL - 46 IS - suppl 59 SP - PA1063 AU - Nitin Jain AU - Vikram Jain AU - Nirmal Jain AU - Mahesh Mishra AU - Arpit Sharma Y1 - 2015/09/01 UR - http://erj.ersjournals.com/content/46/suppl_59/PA1063.abstract N2 - Background: COPD is the 4th leading cause of chronic morbidity & mortality worldwide. It has been now recognized to have extra pulmonary effects with concomitant co morbidities, likely cardiovascular, metabolic syndrome, osteoporosis, psychological disorders , lung cancer & bronchiectasis.Co morbidities clearly contribute to overall morbidity & mortality associated with COPD and understanding their role and potential for treatment is vital.Aims and Objective: To study the co morbidity profile associated in patients with COPD.Methods: A total of 288 patients were diagnosed COPD on the basis of COPD combined assessment test as per GOLD guideline. All patients were screened for routine laboratory investigations including CBC, blood sugar levels, lipid profile, ABG, serum CRP along with 2Dechocardiography, HRCT thorax, x ray chest & PNS with anthropometric measurements.Result: Out of 288 patients with COPD, 61.11% patients has diastolic dysfunction followed by tricuspid regurgitation 58.33% & pulmonary arterial hypertension in 41.66% as a major cardiovascular involvement.Metabolic syndrome 36.11% was diagnosed on basis of international diabetes federation (IDF) ethnicity specific criteria. Bronchiectasis 23.61% & mass lesions 5.90% were diagnosed on HRCT thorax. 52.77% has nasal symptoms out of which 52.63% were having rhino sinusitis on x ray PNS. 31.59% patients were having respiratory infections based on symptoms, raised counts & radiological infiltrates. 25% were having type II respiratory failure. 24.30% were found under weight as per body mass index (BMI).Conclusion: COPD patients should be properly evaluated, as co morbidities are highly associated with it & are often overlooked. ER -